These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 8967878

  • 21. Influence of haemodialysis membranes on beta 2-microglobulin kinetics: in vivo and in vitro studies.
    Zingraff J, Beyne P, Ureña P, Uzan M, Nguyen Khoa Man, Descamps-Latscha B, Drüeke T.
    Nephrol Dial Transplant; 1988; 3(3):284-90. PubMed ID: 3140102
    [Abstract] [Full Text] [Related]

  • 22. Beta 2-microglobulin associated amyloidosis: a vanishing complication of long-term hemodialysis?
    Schwalbe S, Holzhauer M, Schaeffer J, Galanski M, Koch KM, Floege J.
    Kidney Int; 1997 Oct; 52(4):1077-83. PubMed ID: 9328948
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of beta 2-microglobulin removal with high-performance hemodiafiltration.
    Kinugasa E, Akizawa T, Kitaoka T, Koshikawa S.
    Artif Organs; 1988 Feb; 12(1):11-5. PubMed ID: 3281635
    [Abstract] [Full Text] [Related]

  • 24. Removal of digoxin by column for specific adsorption of beta(2)-microglobulin: a potential use for digoxin intoxication.
    Tsuruoka S, Osono E, Nishiki K, Kawaguchi A, Arai T, Furuyoshi S, Saito T, Takata S, Sugimoto K, Kurihara S, Fujimura A.
    Clin Pharmacol Ther; 2001 Jun; 69(6):422-30. PubMed ID: 11406739
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
    Miyata T, Inagi R, Iida Y, Sato M, Yamada N, Oda O, Maeda K, Seo H.
    J Clin Invest; 1994 Feb; 93(2):521-8. PubMed ID: 8113390
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Nontransplant therapy for dialysis-related amyloidosis.
    Copley JB, Lindberg JS.
    Semin Dial; 2001 Feb; 14(2):94-8. PubMed ID: 11264774
    [Abstract] [Full Text] [Related]

  • 33. Dialysis-related beta 2 microglobulin-amyloid arthropathy. Improvement of clinical symptoms after a switch of dialysis membranes.
    Hardouin P, Flipo RM, Foissac-Gegoux P, Dumont A, Duquesnoy B, Delcambre B.
    Clin Rheumatol; 1988 Mar; 7(1):41-5. PubMed ID: 3044672
    [Abstract] [Full Text] [Related]

  • 34. Statistical and parametric analysis of beta-2-microglobulin removal from uremic patients in high flux hemodialysis.
    Lee CJ, Hsiong CH, Chang YL, Cheng CH, Lian JD.
    ASAIO J; 1994 Mar; 40(1):62-6. PubMed ID: 8186494
    [Abstract] [Full Text] [Related]

  • 35. Factors affecting beta 2-microglobulin plasma concentration during hemodialysis.
    Martin-Malo A, Mallol J, Castillo D, Barrio V, Burdiel LG, Perez R, Aljama P.
    Int J Artif Organs; 1989 Aug; 12(8):509-14. PubMed ID: 2681000
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.